Promethazine and Metabolic disorder - a phase IV clinical study of FDA data

Summary:

Metabolic disorder is reported as a side effect among people who take Promethazine (promethazine hydrochloride), especially for people who are male, 30-39 old, also take Pregabalin, and have Hypergammaglobulinaemia.

The phase IV clinical study analyzes which people have Metabolic disorder when taking Promethazine. It is created by eHealthMe based on reports of 31,259 people who have side effects when taking Promethazine from the FDA, and is updated regularly.

What is Promethazine?

Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.

What is Metabolic disorder?

Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues) is found to be associated with 587 drugs and 668 conditions by eHealthMe. Check the latest studies of Metabolic disorder.

On Jul, 05, 2026

31,259 people reported to have side effects when taking Promethazine.
Among them, 14 people (0.04%) have Metabolic disorder.

Could Promethazine cause Metabolic disorder?

Among these 14 people:

What is the gender of people who have Metabolic disorder when taking Promethazine? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Metabolic disorder when taking Promethazine? *

What are other drugs people take besides Promethazine? *

What are other side effects people have besides Metabolic disorder? *

Fatigue (feeling of tiredness): 10 people, 71.43%
Head Injury: 10 people, 71.43%
Hypotension (abnormally low blood pressure): 9 people, 64.29%
Acute Kidney Failure: 6 people, 42.86%
Hepatic Ischaemia (liver does not get enough blood or oxygen, causing injury to liver cells): 6 people, 42.86%
Speech Impairment (Adult) (inability to speak (adult)): 6 people, 42.86%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 6 people, 42.86%
Unresponsive To Stimuli: 6 people, 42.86%
Bradycardia (abnormally slow heart action): 6 people, 42.86%
Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 6 people, 42.86%

What are the existing conditions these people have? *

Neuropathy Peripheral (surface nerve damage): 3 people, 21.43%
Immunodeficiency Common Variable: 3 people, 21.43%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 3 people, 21.43%
Suicide Attempt: 1 person, 7.14%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 7.14%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 7.14%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 7.14%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Promethazine and have Metabolic disorder?

- Check whether Metabolic disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Promethazine:

Promethazine (32,300 reports)

Browse all side effects of Promethazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metabolic disorder:

Metabolic disorder (587 drugs)

Browse all the conditions that are associated with Metabolic disorder:

Metabolic disorder (668 conditions)

Related publications that referenced our studies

Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on promethazine hydrochloride (the active ingredients of Promethazine) and Promethazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.